Antimicrobial Susceptibility Testing Market Outlook Report: Latest Trends and Growth Opportunities by Region

Published On: Jan, 2025
|
Pages: 161

"The Global Antimicrobial Susceptibility Testing Market Size was valued at USD 4.0 billion in 2024 and is projected to reach USD 4.2 billion in 2025. Worldwide sales of Antimicrobial Susceptibility Testing are expected to grow at a significant CAGR of 5.5%, reaching USD 6.9 billion by the end of the forecast period in 2034."

Antimicrobial Susceptibility Testing Market Overview

The antimicrobial susceptibility testing (AST) market is experiencing significant growth due to the rising global concern over antimicrobial resistance (AMR). AST involves testing pathogens to determine their susceptibility to various antimicrobial agents, thereby guiding effective treatment decisions. The increasing prevalence of infectious diseases and the escalating problem of drug-resistant bacteria are driving the need for effective AST solutions. These tests are crucial for identifying specific resistance patterns and ensuring the appropriate use of antibiotics in clinical settings. With healthcare systems worldwide striving to combat the spread of resistant infections, AST plays a vital role in both patient care and the broader public health agenda.

As technology advances, so too does the field of antimicrobial susceptibility testing. Modern AST systems are becoming increasingly automated, offering faster and more accurate results. This shift is driven by the need for high-throughput solutions in hospitals and diagnostic laboratories to handle large volumes of samples efficiently. Furthermore, integration with electronic health records and laboratory information management systems is enhancing the workflow and data management capabilities associated with AST. These developments are improving diagnostic timelines and the overall effectiveness of infection control programs, thereby supporting the growth of the AST market.

North America is the leading region in the Antimicrobial Susceptibility Testing (AST) Market, powered by advanced healthcare infrastructure, rising prevalence of antimicrobial resistance, and substantial investments in clinical diagnostics and research initiatives.

Global Antimicrobial Susceptibility Testing (AST) Market Analysis 2025-2032: Industry Size, Share, Growth Trends, Competition and Forecast Report

Antimicrobial Susceptibility Testing Market: Latest Trends, Drivers, Challenges

One of the key trends in the antimicrobial susceptibility testing market is the rapid adoption of automated systems. These systems reduce human error and increase throughput, enabling laboratories to manage larger sample volumes more efficiently. Additionally, the integration of AI and machine learning technologies is becoming prevalent. These technologies enhance predictive analytics, allowing for more precise interpretation of AST results and prediction of resistance patterns. Such advancements not only streamline laboratory operations but also contribute to more targeted antibiotic stewardship programs, which are crucial in the fight against antibiotic resistance.

Another significant trend is the development of next-generation sequencing (NGS) and molecular diagnostics in AST. These technologies offer the potential for faster, more accurate detection of resistance genes compared to traditional culture-based methods. NGS, for example, can identify resistance genes directly from clinical samples without the need for culturing, significantly reducing the time to diagnosis. Molecular diagnostics are also enhancing the specificity of AST, allowing for the detection of resistance mechanisms at the genetic level, which aids in the formulation of more effective treatment strategies.

The primary drivers of the antimicrobial susceptibility testing market include the growing prevalence of infectious diseases and the rising incidence of drug-resistant bacteria. As antibiotic resistance becomes a more pressing global health issue, the demand for effective AST solutions is increasing. Healthcare facilities are prioritizing the adoption of advanced AST technologies to ensure accurate treatment and reduce the spread of resistant infections. Moreover, government initiatives promoting antibiotic stewardship programs and improving healthcare infrastructure are further stimulating the adoption of AST systems. These programs often mandate regular monitoring and reporting of antibiotic resistance, which directly drives the demand for susceptibility testing.

Despite its critical importance, the antimicrobial susceptibility testing market faces several challenges. The high cost of advanced AST systems can be a barrier for adoption, particularly in low-resource settings. Furthermore, the complexity of some modern AST technologies requires significant training and expertise, which may not be readily available in all healthcare facilities. There is also the challenge of keeping pace with rapidly evolving bacteria and resistance mechanisms, which can make existing testing methods obsolete. Additionally, regulatory hurdles in different countries can delay the introduction of new AST technologies into the market. Addressing these challenges is essential for the continued advancement and effectiveness of antimicrobial susceptibility testing practices.

Major Players in the Antimicrobial Susceptibility Testing Market

1. Bio-Rad Laboratories, Inc.
2. Becton, Dickinson and Company
3. Thermo Fisher Scientific Inc.
4. Merck KGaA
5. Agilent Technologies, Inc.
6. bioMérieux SA
7. Bruker Corporation
8. CondaLab
9. Creative Diagnostics
10. HiMedia Laboratories
11. Synbiosis
12. Danaher Corporation
13. Accelerate Diagnostics, Inc.
14. Alifax S.r.l.
15. Liofilchem S.r.l.

Market Scope

Parameter

Detail

Base Year

2024

Estimated Year

2025

Forecast Period

2026-2032

Market Size-Units

USD billion

Market Splits Covered

By Product, By Method, By Application,By End User

Countries Covered

North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
Asia-Pacific (China, India, Japan, Australia, Rest of APAC)
The Middle East and Africa (Middle East, Africa)
South and Central America (Brazil, Argentina, Rest of SCA)

Analysis Covered

Latest Trends, Driving Factors, Challenges, Trade Analysis, Price Analysis, Supply-Chain Analysis, Competitive Landscape, Company Strategies

Customization

10% free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed

Post-Sale Support

4 analyst hours, available up to 4 weeks

Delivery Format

The Latest Updated PDF and Excel Data file

Market Segmentation

By Product:

  • Manual Testing Products
  • Automated Testing Systems
  • Consumables

By Method:

 

  • Disk Diffusion
  • Dilution
  • E-test

By Application:

  • Clinical Diagnostics
  • Drug Discovery and Development
  • Others

By End User:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes

By Regian

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Rest of APAC)
  • The Middle East and Africa (Middle East, Africa)
  • South and Central America (Brazil, Argentina, Rest of SCA)

   

  

Get Free Sample

At OG Analysis, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.

Start Now! Please fill the form below for your free sample.

Why Request a Free Sample?

Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.

Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.

Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.

Embark on your journey towards strategic decision-making by requesting a free sample from OG Analysis. Experience the caliber of insights that can transform the way you approach your business challenges.

You can purchase individual sections of this report. Explore pricing options for specific sections.

FAQ's

The Antimicrobial Susceptibility Testing Market is estimated to reach USD 6.1 billion by 2032.

The Global Antimicrobial Susceptibility Testing Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period from 2025 to 2032.

The Global Antimicrobial Susceptibility Testing Market is estimated to generate USD 4 billion in revenue in 2024.

License

Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM

Need something within your budget? NO WORRIES! WE GOT YOU COVERED!

Related Products

Medical Gas Pipeline System Market Analysis and Outlook Report: Industry Size, Share, Growth Trends, and Forecast (2025-2034)

The Medical Gas Pipeline System Market serves as a foundational element in modern healthcare infrastructure, delivering vital gases such as oxygen, nitrous oxide, medical air, and vacuum to various departments in hospitals and healthcare facilities. These systems ensure uninterrupted gas flow to operating rooms, intensive care units, emergency wards, and patient bedsides, playing a critical role in patient safety and treatment outcomes. Built on a network of pipelines, control panels, zone valves, and alarm systems, medical gas pipeline systems must comply with rigorous international standards to guarantee purity, pressure consistency, and fault tolerance. The demand for these systems is rising sharply with the global expansion of hospitals, particularly in developing regions where healthcare access is rapidly improving. Simultaneously, retrofitting and modernization projects in established hospitals are driving upgrades to digital and automated pipeline systems. In 2024, market developments have been largely shaped by growing investments in healthcare infrastructure and increased awareness of medical gas delivery safety—especially post-pandemic. Manufacturers are focusing on offering modular and scalable pipeline solutions tailored for both large urban hospitals and smaller regional clinics. Integration with centralized monitoring systems is becoming standard, allowing real-time tracking of gas flow, leakage detection, and automated alerts. There is a notable shift toward environmentally friendly systems, with some providers incorporating gas recycling or low-leakage technology to reduce waste. Governments and private hospital chains are increasingly prioritizing projects that not only meet safety codes but also improve energy efficiency and maintenance efficiency. As healthcare becomes more digitized, medical gas pipeline systems are evolving into smart, connected infrastructure—crucial not only for operational efficiency but also for clinical excellence and emergency preparedness. Key Takeaways – Medical Gas Pipeline System Market Medical gas pipeline systems are essential for the delivery of life-supporting gases and vacuum in hospitals, making them critical to patient care and clinical efficiency. Demand is increasing globally due to expanding healthcare infrastructure, particularly in emerging economies where new hospitals and clinics are being rapidly constructed. Digital integration is trending, with hospitals seeking centralized control systems for real-time monitoring, alarm management, and leak detection. Modular and customizable pipeline systems are gaining traction, allowing tailored installations that fit unique architectural and operational requirements. Energy-efficient designs and low-leakage materials are being prioritized to support sustainability goals and reduce operational gas losses. One major driver is the surge in surgical and ICU procedures requiring reliable oxygen and vacuum supply, especially post-COVID-19. Governments are mandating stricter compliance to safety standards such as NFPA 99, ISO 7396, and HTM 02-01, pushing healthcare providers to upgrade older systems. Integration with hospital building management systems (BMS) is improving operational transparency and response times in emergency scenarios. Upfront installation costs and the need for skilled labor remain key challenges for small- and medium-sized healthcare facilities. Another challenge is the logistical complexity of retrofitting existing hospitals with modern systems without disrupting ongoing medical services. North America and Europe dominate the market in terms of compliance-driven upgrades, while Asia-Pacific leads in new installations due to hospital construction booms. Manufacturers are increasingly offering turnkey services including system design, installation, and maintenance to improve customer retention and long-term engagement. Technological collaborations between medical device companies and engineering firms are enabling smarter, data-driven gas pipeline infrastructure. Hospital chains are favoring multi-site standardized pipeline systems to streamline operations and maintenance across facilities. Market players are innovating with touch-screen control panels, wireless alert systems, and predictive maintenance tools to elevate system usability and safety. Parameter Detail Base Year 2024 Estimated Year 2025 Forecast Period 2026-2032 Market Size-Units USD billion Market Splits Covered By Product Type, By Application, By End User, By Technology, By Distribution Channel Countries Covered North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) Analysis Covered Latest Trends, Driving Factors, Challenges, Trade Analysis, Price Analysis, Supply-Chain Analysis, Competitive Landscape, Company Strategies Customization 10% free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed Post-Sale Support 4 analyst hours, available up to 4 weeks Delivery Format The Latest Updated PDF and Excel Datafile

Published:May-2025

Omega-3 Fatty Acids Market Analysis and Outlook Report: Industry Size, Share, Growth Trends, and Forecast (2025-2032)

Omega-3 fatty acids are essential polyunsaturated fats, primarily including alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). These nutrients are vital for maintaining heart health, supporting brain function, and reducing inflammation. They are commonly found in fish oils, certain plant oils, and are also available as dietary supplements. Market Insights: Rising Consumer Awareness: There's an increasing global recognition of the health benefits associated with omega-3 fatty acids, leading to higher consumption of supplements and fortified foods. Diversification of Sources: Due to sustainability concerns and dietary preferences, there's a notable shift toward plant-based and algal sources of omega-3s, catering to vegetarian and vegan consumers. Product Innovation: Manufacturers are developing new formulations and delivery methods, such as gummies, emulsions, and fortified foods, to enhance bioavailability and consumer appeal. Prevalence of Chronic Diseases: The rising incidence of cardiovascular diseases and mental health disorders has led to a greater emphasis on preventive healthcare, boosting the demand for omega-3 supplements. Aging Population: An increasing elderly demographic seeks omega-3s for their potential benefits in cognitive health and reducing age-related ailments. Regulatory Support: Government initiatives and health organizations are endorsing the consumption of omega-3s, further propelling market growth. Report Scope Table body { font-family: Arial, sans-serif; padding: 20px; background-color: #f9f9f9; } table { width: 80%; border-collapse: collapse; margin-top: 20px; background-color: #FFFFFF; /* white shade */ table-layout: fixed; /* Ensures equal column widths */ } th, td { padding: 10px; border: 1px solid #ccc; vertical-align: top; width: 50%; /* Equal column width */ } th { background-color: #cce6ff; /* Slightly darker blue for header */ text-align: left; } .upload-section { margin-top: 30px; } Report Scope Overview Report Scope Details Base Year 2024 Compound Annual Growth Rate (CAGR) (%) 2025 to 2034 Market Forecast Period 2025 to 2034 Market Forecast Units USD Billion Segments Covered By Type, By Source, By Application and By Distribution Channel Region Covered North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa Countries Covered USA, Canada, Mexico Germany, UK, France, Spain, Italy, China, India, Japan, Australia, South Korea, Saudi Arabia, UAE, Iran, South Africa, Brazil, Argentina Key Companies Profiled BASF SE, Cargill, Incorporated, DSM, ADM, Kerry Group Plc, Croda International Plc, Orkla, Corbion, Aker BioMarine, Polaris, Epax Norway AS, Lonza Group, Golden Omega, Omega Protein Corporation, GC Rieber Oils Customization Scope 10% Free Customization Post-Sale Analyst Support 4 Weeks Delivery Format PDF and Excel via Email (PPT/Word available on special request)

Published:Apr-2025

Disposable Medical Needle Market Analysis and Outlook Report: Industry Size, Share, Growth Trends, and Forecast (2025-2034)

The Disposable Medical Needle Market plays a vital role in global healthcare infrastructure, providing safe and hygienic solutions for various medical procedures, including drug delivery, blood collection, vaccination, and intravenous therapy. As healthcare providers continue to emphasize infection control and patient safety, the demand for single-use needles has surged. These needles are designed for one-time use to prevent cross-contamination and the transmission of infectious diseases. The market encompasses a wide array of needle types such as hypodermic needles, blood collection needles, and suture needles, among others. A growing number of surgeries, immunization programs, and chronic disease cases are fueling consistent demand, making disposable needles an indispensable element in hospitals, clinics, diagnostic centers, and home healthcare settings. In recent years, the Disposable Medical Needle Market has experienced a technological shift with increasing incorporation of safety-engineered needles that feature retractable designs and needle shielding mechanisms to reduce needlestick injuries. Regulatory policies in developed countries have further encouraged the adoption of such devices, pushing manufacturers to innovate. Emerging economies are also witnessing a rising uptake due to expanding public health initiatives and improving healthcare infrastructure. Furthermore, the rise in point-of-care diagnostics and home-based treatments is broadening the market’s consumer base. The market’s competitive landscape is defined by strategic collaborations, geographic expansions, and the development of cost-effective, eco-conscious solutions tailored to meet local and global medical standards. Key Takeaways Increasing prevalence of chronic diseases such as diabetes and cancer is driving sustained demand for disposable medical needles for ongoing treatments and diagnostics. Government immunization programs, especially in developing regions, are significantly boosting the consumption of single-use needles in mass vaccination campaigns. Stringent health and safety regulations in North America and Europe are promoting the use of safety-engineered disposable needles to reduce occupational hazards. Technological advancements are enabling the production of ultra-thin, pain-minimizing needles that enhance patient comfort during routine and specialty procedures. Asia-Pacific is emerging as the fastest-growing regional market due to healthcare infrastructure development, medical tourism, and favorable regulatory reforms. Rising awareness among healthcare workers about the dangers of needlestick injuries is fostering adoption of auto-disable and retractable needle types. Single-use needle demand is gaining traction in home-based care settings, especially for insulin administration and self-injectable medications. Supply chain disruptions have led to an increase in regional production capabilities and strategic sourcing to ensure uninterrupted needle supply. Eco-friendly initiatives are encouraging the development of biodegradable or recyclable disposable needles to minimize medical waste. Public-private partnerships are expanding healthcare access and creating demand for low-cost disposable medical supplies in underserved areas. Online distribution and e-commerce platforms are enabling smaller clinics and consumers to access a variety of disposable medical needle products more conveniently. Leading companies are pursuing acquisitions and R&D investments to develop patent-protected needle designs and expand their safety product portfolios. Hospital consolidations and group purchasing organizations (GPOs) are influencing pricing strategies and supplier competitiveness within the market. Localized manufacturing is helping companies reduce costs and comply with domestic regulatory standards, boosting market penetration in low- and middle-income countries. Ongoing innovation in needle coatings and materials is aimed at reducing patient discomfort, improving durability, and enhancing sterility assurance. Parameter Detail Base Year 2024 Estimated Year 2025 Forecast Period 2026-2032 Market Size-Units USD billion Market Splits Covered By Product Type, By Application, By End User, By Technology, By Distribution Channel Countries Covered North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) Analysis Covered Latest Trends, Driving Factors, Challenges, Trade Analysis, Price Analysis, Supply-Chain Analysis, Competitive Landscape, Company Strategies Customization 10% free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed Post-Sale Support 4 analyst hours, available up to 4 weeks Delivery Format The Latest Updated PDF and Excel Datafile

Published:May-2025